Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Jul. 30, 2011	Jul. 31, 2010
Cash flows from operating activities:
Net income	$ 683,867	$ 487,090
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	88,092	86,776
Amortization of intangibles	1,079	4,189
Stock-based compensation expense	38,806	38,266
Gain on sale of business	(6,500)	(859)
Excess tax benefit-stock options	(37,296)	(153)
Deferred income taxes	(6,989)	(16,233)
Non-cash portion of special charge		487
Other non-cash activity	1,185	1,420
Changes in operating assets and liabilities	(91,875)	115,916
Total adjustments	(13,498)	229,809
Net cash provided by operating activities	670,369	716,899
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(3,132,633)	(2,439,506)
Maturities of short-term available-for-sale investments	2,334,311	2,015,706
Sales of short-term available-for-sale investments	259,385	84,941
Proceeds related to sale of businesses	10,000	63,036
Payments for acquisitions, net of cash acquired	(13,988)
Additions to property, plant and equipment	(96,665)	(73,794)
(Increase) decrease in other assets	(6,683)	3,668
Net cash used for investing activities	(646,273)	(345,949)
Cash flows from financing activities:
Proceeds from long-term debt	515,507
Term loan repayments	(24,767)
Dividend payments to shareholders	(206,802)	(184,375)
Repurchase of common stock	(247,440)	(4,047)
Net proceeds from employee stock plans	189,239	174,002
Increase in other financing activities	365	502
Excess tax benefit-stock options	37,296	153
Net cash provided by (used for) financing activities	263,398	(13,765)
Effect of exchange rate changes on cash	327	(3,485)
Net increase in cash and cash equivalents	287,821	353,700
Cash and cash equivalents at beginning of period	1,070,000	639,729
Cash and cash equivalents at end of period	$ 1,357,821	$ 993,429